Loading...
OTCM
DGEN
Market cap0USD
Dec 10, Last price  
0.00USD
Name

Deltagen Inc

Chart & Performance

D1W1MN
OTCM:DGEN chart
P/E
—
P/S
—
EPS
0.00
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
263k
-74.27%
01,240,0002,080,0009,910,00017,690,0006,701,0009,780,0003,413,0002,926,0001,357,0001,987,0001,054,0001,022,000263,000
Net income
76k
P
0-13,847,000-32,221,000-48,457,000-107,168,000-152,0004,368,000-95,00037,000-687,000-685,000-1,165,000-4,418,00076,000
CFO
90k
P
-7,248,000-13,174,000-41,384,000-59,472,0002,072,000-1,022,000-667,000-2,175,000-665,00090,000
Dividend
May 17, 20070.05 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was incorporated in 1999 and is headquartered in San Mateo, California.
URL
IPO date
Aug 03, 2000
Employees
Domiciled in
US
Incorporated in
US

Valuation

No data to show